Jin Wang

Practice Areas

MS. WANG SPECIALIZES IN ANTITRUST LAW, COMPETITION LAW AND REGULATORY MATTERS.

Ms. Wang has more than 10 years of experience in advising clients on all aspects of Chinese competition law, including merger control, administrative investigations, and antitrust compliance. She has advised clients in a broad range of industry sectors, including healthcare, automobiles, chemicals, consumer products and retail, real estate, container shipping, energy and natural resources, high-tech, infrastructure and transportation, and private equity.

Career

Before joining the firm, Ms. Wang worked in the Beijing office of a leading international law firm for five years.

Languages Spoken

-Chinese

-English

Education

Experience

Antitrust investigation

Advised an international pharmaceutical manufacturer on antitrust issues in its proposed cooperation with an online diagnostics and pharmaceutical distribution business

Advised Eastman Chemical Company, a global manufacturer of chemical products, on the first abuse of dominance investigation initiated by the SAIC in the industry, as well as on an NDRC investigation into resale price maintenance

Advised three state-owned port groups (Tianjin Port, Dalian Port and Yantian Port) on reaching favorable results in an NDRC antitrust investigation into alleged abuses of dominance

Advised Medtronic, a multinational medical device company, in successfully obtaining reduced fines in an NDRC investigation

Advised Chrysler, Daimler and Chang’an Ford in successfully obtaining reduced fines in three out of the five published NDRC resale price maintenance cases against multinational automobile companies

Advised three multinational automobile companies in similar resale price maintenance investigations initiated by the NDRC

Advised a leading global high-tech company in handling an SAIC antitrust investigation

Advised Höegh Autoliners, an international shipping company, on the first successful defense against an NDRC cartel investigation in the PRC

Advised a leading US toy manufacturing company on its defense against allegations by the local competition law enforcement that the company breached the PRC Anti-unfair Competition Law

Advised a leading Swiss medical device manufacturer on responding to allegations of abuse of dominant position in China

Advised several multinational and Chinese domestic manufacturing companies on antitrust issues arising from their cooperation and distribution agreements

Advised a multinational pharmaceutical company and several state-owned company groups in setting up their internal antitrust compliance programs

Merger control

Advised Danaher on the PRC merger filing for its USD 21.4 billion acquisition of GE Healthcare Life Sciences’ Biopharma Business

Advised Blackstone on its acquisitions of real estate in China and its recent acquisition of real estate assets in Japan

Advised Warburg Pincus LLC on the PRC merger control filing for its acquisition of shares of P&D Investment Holding Limited

Advised Mylan on its acquisition of Sebivo from Novartis

Advised DKSH on the acquisition of DKSH’s pharmaceutical distribution business in China by Warburg Pincus LLC

Advised Hyundai Motor Company on its joint venture with Aptiv PLC to develop autonomous driving technology

Advised Beijing Mercedes-Benz Sales Service Co., Ltd. (BMBS) on the acquisition of the distribution business of Denza through contractual arrangement

Advised TPG on the investment in APM Monaco by a consortium led by TPG

Advised TPG on its acquisition of Genting’s Dream Cruises business

Advised GE on its joint venture with Chaowei Power Holdings Limited to market a sodium-nickel-chloride battery

Advised Chindex on its PRC merger control filing for the USD 461 million takeover of Chindex by a group led by private equity firm TPG and Shanghai Fosun Pharmaceutical

Advised CNPC on its PRC merger control filing for its acquisition of a Russian energy company

Advised Daimler AG on its PRC merger control filing for its carbon-fiber reinforced plastic components manufacturing joint venture with Toray and ACE and on its other antitrust matters

Advised Daimler AG and Robert Bosch on its PRC merger control filing for their joint venture for manufacturing electric motors for electric vehicles and hybrid electric vehicles

Advised Davidson Kempner, GLG Partners, Centaurus Capital and Senrigan Capital on PRC merger control analysis

Advised Eni S.p.A. and Rosneft Oil Company on the PRC merger control filing for their joint venture for the exploration of oil and gas and for the development, production and marketing of oil and gas products

Advised Mahle on the PRC merger control filing for its acquisition of Behr

Advised UGL on the PRC merger control filing for the sale of shares in DTZ to TPG

Advised Virgin Atlantic Airlines on its PRC merger control filing for its joint venture with Delta Airlines

Advised United Technologies Corporation on various issues under the PRC Anti-Monopoly Law in its proposed acquisition in China